2026Eyl
ABBV Sep 2026 · Sell
Sell. At the $256.46 report-date price, AbbVie trades above the $180.11 Fair value and $250.84 Potential value.Latest published research · analyzed 2026-09-08 · stale · sources stale
ABBV · Archive
Daha önce yayımlanmış sürümleri, derecelendirmeleri ve fiyat eğilimlerini okuyun. Her satır kendi analiz tarihini belirtir.
USD 256,46
2026May
ABBV May 2026 · Hold
AbbVie is successfully navigating the Humira patent cliff by driving strong growth in its newer immunology assets, Skyrizi and Rinvoq. The company remains a highly cash-generative powerhouse capable of supporting a robust and growing dividend.Historical archived edition · analyzed 2026-05-08